GleanMark

EPSILOGEN Trademark

EPSILOGEN is a USPTO trademark filed by Epsilogen Ltd. Status: Registered.

Trademark Facts

MarkEPSILOGEN
Serial Number88885762
Registration Number6505086
StatusRegistered
Filing Date2020-04-24
Registration Date2021-10-05
Mark TypeWord
Nice Classes005 (Pharmaceuticals)
OwnerEpsilogen Ltd
Attorney of RecordSusan Piascik Christoff
Prosecution Events15
Latest EventR.PR on 2021-10-05

Goods & Services

Pharmaceutical drugs for suppressing tumors; pharmaceutical drugs for treating malignant tumors; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for suppressing tumors; medicine for treating malignant tumors; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use | Scientific and technological services, namely, scientific research in the field of pharmaceutical research and development and research and design relating thereto; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research in the field of cancer treatment; clinical trials for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services of technology in the fields of oncology, immunology and immuno-oncology | Medical treatment services of cancerous diseases; medical screening of cancerous diseases; medical diagnostic monitoring, testing, and analysis services; medical services, namely, diagnosis and treatment of cancerous diseases; pharmaceutical services, namely, dispensing pharmaceuticals; pharmaceutical services, namely, pharmaceutical consultation; pharmaceutical services, namely, pharmaceutical compounding services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons by medical laboratories; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases by medical laboratories; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis by medical laboratories; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology

Related